These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 747986)
1. The response of glucose, insulin and FFA to intravenous glucose and glucagon in elderly subjects in the course of morning and afternoon tests. Coscelli C; Alpi O; Butturini U Chronobiologia; 1978; 5(4):387-90. PubMed ID: 747986 [TBL] [Abstract][Full Text] [Related]
2. Diurnal variation in blood sugar and serum insulin in response to glucose and/or glucagon in healthy subjects. Melani F; Verrillo A; Marasco M; Rivellese A; Osorio J; Bertolini MG Horm Metab Res; 1976 Mar; 8(2):85-8. PubMed ID: 944163 [TBL] [Abstract][Full Text] [Related]
3. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension. Iannello S; Campione R; Belfiore F Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544 [TBL] [Abstract][Full Text] [Related]
4. [Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests]. Gorini M; Ghizzi A; Carlo Stella C; De Caro L Minerva Med; 1985 Sep; 76(37):1663-75. PubMed ID: 2995870 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance. Ratzmann KP; Witt S; Schulz B Diabete Metab; 1982 Sep; 8(3):223-8. PubMed ID: 6754494 [TBL] [Abstract][Full Text] [Related]
6. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091 [TBL] [Abstract][Full Text] [Related]
7. Effect of exogenous glucagon on the concentrations of free fatty acids, glucose and immunoreactive insulin during dynamic exercise and restitution in healthy subjects. Markiewicz K; Cholewa M; Górski L Acta Physiol Pol; 1979; 30(4):427-35. PubMed ID: 506749 [No Abstract] [Full Text] [Related]
8. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1. Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561 [TBL] [Abstract][Full Text] [Related]
9. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Vilsbøll T; Krarup T; Madsbad S; Holst JJ Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441 [TBL] [Abstract][Full Text] [Related]
10. Metabolic and hormonal responses during a glucose controlled insulin infusion (Biostator) in subjects with impaired glucose tolerance. Ratzmann KP; Schneider U; Peters U; Ziegler M; Schulz B Exp Clin Endocrinol; 1984 May; 83(3):334-42. PubMed ID: 6381073 [TBL] [Abstract][Full Text] [Related]
11. Plasma insulin, glucose and free fatty acid (FFA) response to various stimuli in the premature infant. Grasso S; Saporito N; Messina A; Reitano G Diabetes; 1968; 17():306. PubMed ID: 4870771 [No Abstract] [Full Text] [Related]
12. Circadian variation in glucose tolerance and associated changes in plasma insulin and somatostatin levels in normal volunteers. Verrillo A; de Teresa A; Rucco E Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2261-6. PubMed ID: 6152172 [TBL] [Abstract][Full Text] [Related]
13. [Effects of adrenergic beta-blocking agents on the serum insulin and glucagon response to oral glucose load in normal and diabetic subjects]. Ferlito S; Volpicelli D; Del Campo F; Romano F; Modica L Clin Ter; 1981 May; 97(4):333-47. PubMed ID: 6113914 [No Abstract] [Full Text] [Related]
14. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus. Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528 [TBL] [Abstract][Full Text] [Related]
15. Patterns of glucose intolerance and free fatty acid behavior in viral hepatitis. Granot C; Bar-On H; Shafrir E Isr J Med Sci; 1981 Jan; 17(1):12-8. PubMed ID: 7007283 [TBL] [Abstract][Full Text] [Related]
16. [Effect of glucagon and of the glucose tolerance test on incretion of the somatotrophic hormone in normal subjects. Comparison of results]. Giordano G; Marugo M; Minuto F; Barreca T Folia Endocrinol; 1971; 24(3):289-97. PubMed ID: 5171731 [No Abstract] [Full Text] [Related]
17. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277 [TBL] [Abstract][Full Text] [Related]
18. Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies, insulin, and human chorionic somatomammotropin during the last trimester. Persson B; Lunell NO Am J Obstet Gynecol; 1975 Jul; 122(6):737-45. PubMed ID: 1155514 [TBL] [Abstract][Full Text] [Related]
19. Diurnal variations in insulin secretion and insulin sensitivity in aged subjects. Pisu E; Diana A; Lombardi A; Cassader M; Pagano G Acta Diabetol Lat; 1980; 17(2):153-60. PubMed ID: 7004042 [TBL] [Abstract][Full Text] [Related]